Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome.
about
Advances in cholangiocyte immunobiologyCirrhosis and autoimmune liver disease: Current understandingHepatopulmonary Syndrome and Liver Transplantation: A Recent Review of the LiteratureThe association between clinical symptoms, laboratory findings and serum endothelin 1 concentrations, in cirrhotic patients with and without hepatopulmonary syndrome.The relationship between hepatopulmonary syndrome and altitude.Regulation of biliary proliferation by neuroendocrine factors: implications for the pathogenesis of cholestatic liver diseases.Regulation of transforming growth factor-β1-dependent integrin β6 expression by p38 mitogen-activated protein kinase in bile duct epithelial cellsFibrosis in autoimmune and cholestatic liver diseaseElevated levels of endothelin-1 in hepatic venous blood are associated with intrapulmonary vasodilatation in humans.Role of endothelin in systemic and portal resistance in cirrhosis.Cholangiocyte proliferation and liver fibrosis.Autocrine regulation of biliary pathology by activated cholangiocytes.Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expressionThe role of receptor tyrosine kinase activation in cholangiocytes and pulmonary vascular endothelium in experimental hepatopulmonary syndrome.Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspectsEndothelin-1 activation of the endothelin B receptor modulates pulmonary endothelial CX3CL1 and contributes to pulmonary angiogenesis in experimental hepatopulmonary syndrome.Hypoxia among patients on the liver-transplant waiting list.Review article: Update on current and emergent data on hepatopulmonary syndrome.
P2860
Q27002954-BADBD2DF-8DF2-420C-BFE2-BD6F6DBD37CFQ28070154-DE387D55-0AFA-46C3-BDFE-CA618920793FQ28073854-1F15D4B1-8BEF-46CF-849E-5465D0095253Q33596500-C24A3A1A-8B15-44D8-B49E-F43427721EFCQ33810062-8F76D9D6-A653-4AA3-BBFF-B35B217A1665Q34755613-68956D9B-2767-465E-99AC-E40A00647D8AQ34868170-B3CFBB40-A6AD-4959-B6F0-ED3816E4BA9FQ35098677-E6995B49-0C7D-4188-8107-D7BD607C4E10Q35991529-874C3B39-CDEE-4DD6-B618-873A0F9404B0Q36564609-4CED4578-1DBD-44F6-8BE7-9478818FEC45Q37175438-0195B4A7-2D1F-44F6-A119-E1D0F24E7A6AQ37175512-F39ADA60-2C3A-46D1-8D9C-B445E3273002Q37253350-3CA362CA-5ED9-4C1D-B865-CAE1C643C3CBQ37575693-E13C8F8F-6CC2-48DD-B4D3-D2C4AC6CB4C1Q38268612-A0EA3D9B-3C07-4857-A8A8-508030EF08F4Q40279217-C8B23881-54C4-4C07-B37A-6758EE548409Q42095414-D4597242-1799-46F0-B370-4036EDE99B7EQ52620669-B1CFB0CF-A195-4E21-ADE5-9086A1B1CA83
P2860
Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Cholangiocyte endothelin 1 and ...... ntal hepatopulmonary syndrome.
@ast
Cholangiocyte endothelin 1 and ...... ntal hepatopulmonary syndrome.
@en
type
label
Cholangiocyte endothelin 1 and ...... ntal hepatopulmonary syndrome.
@ast
Cholangiocyte endothelin 1 and ...... ntal hepatopulmonary syndrome.
@en
prefLabel
Cholangiocyte endothelin 1 and ...... ntal hepatopulmonary syndrome.
@ast
Cholangiocyte endothelin 1 and ...... ntal hepatopulmonary syndrome.
@en
P2093
P2860
P1433
P1476
Cholangiocyte endothelin 1 and ...... ntal hepatopulmonary syndrome.
@en
P2093
Andra R Frost
Cecil R Stockard
Ju-Zhong Sun
Junlan Zhang
Liping Tang
Michael B Fallon
Wenguang Feng
William E Grizzle
Yiqun Ling
P2860
P304
P356
10.1053/J.GASTRO.2005.05.050
P407
P577
2005-08-01T00:00:00Z